2024-12-10 Odimma is part of the 10 new projects to be supported by the Paris Saclay Cancer Cluster Read more
2024-11-06 Odimma Therapeutics to present a poster on preclinical data obtained with its immunization platform ODI-2001at SITC2024, in Houston, Texas, November 6-10 2024 Read more
2024-09-11 ODIMMA THERAPEUTICS WILL BE PRESENTING PRECLINICAL DATA AT THE ANNUAL ESMO CONGRESS, BARCELONA, SPAIN Read more
2024-07-15 Odimma Therapeutics receives the Seal of Excellence form the European Commission Read more
2024-03-01 ODIMMA THERAPEUTICS WILL BE PARTICIPATING IN THE BIO-EUROPE SPRING 2024 MEETING, BARCELONA, MARCH 18-20, 2024. Read more
2024-01-22 ODIMMA THERAPEUTICS JOINS PSSC CONNECT THE FIRST EUROPEAN BIOCLUSTER DEDICATED TO ONCOLOGY. Read more
2023-09-19 ODIMMA THERAPEUTICS PRESENT AT THE SACHS 2023 INVESTMENT FORUM Read more
2023-05-02 ODIMMA THERAPEUTICS SECURES €2 MILLION TO COMPLETE THE PREPARATION OF ITS FIRST-IN-MAN CLINICAL TRIAL Read more
2023-03-28 ODIMMA THERAPEUTICS PRESENT AT BIO-EUROPE SPRING 2023 Read more
2023-02-13 ODIMMA PARTNERS WITH MYNEO FOR THE CLINICAL DEVELOPMENT OF ITS PERSONALIZED DNA-BASED CANCER IMMUNOTHERAPY Read more
2022-12-07 ODIMMA ANNOUNCES ITS PARTNERSHIP WITH TOUCHLIGHT TO SUPPLY SYNTHETIC DNA FOR ITS PERSONALISED CANCER THERAPY CANDIDATE Read more
2022-11-30 ODIMMA THERAPEUTICS IS THE WINNER OF THE MERCK GROUP'S SPECIAL PRIZE AWARD AT BIOFIT 2022 Read more
2022-11-01 ODIMMA THERAPEUTICS HAS BEEN SELECTED TO BE PART OF THE WICLUB HEALTH #2 FINALISTS Read more
2022-09-01 ODIMMA THERAPEUTICS HEADQUARTER MOVES TO PH8, THE BUSINESS INCUBATOR DEDICATED TO HEALTH TECHNOLOGIES Read more
2022-04-27 ODIMMA THERAPEUTICS PRESENTS AT THE 5TH NEOANTIGEN SUMMIT EUROPE Read more
2022-04-17 ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY Read more
2021-03-25 ODIMMA THERAPEUTICS IS PART OF THE NEW SELECTION OF THE "100 START-UPS” TO INVEST IN 2021 Read more
2020-11-26 JESSICA MATTA IS THE WINNER OF THE "LES FEMMES DE L'ÉCONOMIE" AWARD FOR PROMISING WOMEN ENTREPRENEURS Read more
2019-12-18 ODIMMA RAISES € 2M IN SEED FUNDING TO ADVANCE ITS PERSONALIZED CANCER IMMUNOTHERAPY PLATFORM Read more